Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Hepatitis A and CCR2[original query] |
|---|
| Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology (Baltimore, Md.) 2003 Dec 38 (6): 1468-76. Hellier Simon, Frodsham Angela J, Hennig Branwen J W, Klenerman Paul, Knapp Suzanne, Ramaley Patricia, Satsangi Jack, Wright Mark, Zhang Lyna, Thomas Howard C, Thursz Mark, Hill Adrian V |
| Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003 Feb 124 (2): 352-60. Promrat Kittichai, McDermott David H, Gonzalez Carlos M, Kleiner David E, Koziol Deloris E, Lessie Matthew, Merrell Maya, Soza Alejandro, Heller Theo, Ghany Marc, Park Yoon, Alter Harvey J, Hoofnagle Jay H, Murphy Philip M, Liang T Ja |
| Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies. Journal of viral hepatitis 2004 Jul 11 (4): 319-23. Ruiz-Ferrer M, Barroso N, Antiñolo G, Aguilar-Reina |
| CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Intervirology 2004 47 (2): 114-20. Konishi Ichiro, Horiike Norio, Hiasa Yoichi, Michitaka Kojiro, Onji Morika |
| Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients. Clinical and experimental immunology 2004 May 136 (2): 328-33. Mascheretti S, Hinrichsen H, Ross S, Buggisch P, Hampe J, Foelsch UR, Schreiber S |
| The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut 2005 Aug 54 (8): 1157-61. Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, McKiernan S, Kelleher |
| RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. Journal of Korean medical science 2007 Jun 22 (3): 529-35. Cheong Jae Youn, Cho Sung Won, Choi Jeong Young, Lee Jung A, Kim Min Ho, Lee Jong Eun, Hahm Ki Baik, Kim Jin Ho |
| CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population. World journal of gastroenterology : WJG 2007 Apr 13 (15): 2187-92. Montes-Cano M-A, Garcia-Lozano J-R, Aguilar-Reina J, Romero-Gomez M, Barroso N, Nunez-Roldan A, Gonzalez-Escribano M |
| Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. European journal of gastroenterology & hepatology 2007 May 19 (5): 425-31. Nahon Pierre, Sutton Angela, Rufat Pierre, Faisant Charles, Simon Chantal, Barget Nathalie, Trinchet Jean-Claude, Beaugrand Michel, Gattegno Liliane, Charnaux Nathal |
| Protective effect of CCR5-?32 against HIV infection by the heterosexual mode of transmission in a Polish population. AIDS research and human retroviruses 2013 Jan 29 (1): 54-60. Zwoli?ska Katarzyna, Knysz Brygida, Rybka Katarzyna, Pazgan-Simon Monika, G?siorowski Jacek, Sobczy?ski Maciej, G?adysz Andrzej, Piasecki Egbe |
| Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clinical and experimental immunology 2012 Sep 169 (3): 302-10. Degré D, Lemmers A, Gustot T, Ouziel R, Trépo E, Demetter P, Verset L, Quertinmont E, Vercruysse V, Le Moine O, Devière J, Moreno |
| Possible Impact of 190G > A CCR2 and ?32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report. International journal of environmental research and public health 2017 Feb 14 (2): . Ganczak Maria, Skonieczna-?ydecka Karolina, Drozd-D?browska Marzena, Adler Gra?y |
| Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. British journal of biomedical science 2018 Sep . El-Bendary M, Neamatallah M, Elalfy H, Besheer T, El-Setouhy M, Youssef M M, Zein M, Elhammady D, Hegazy A, Esmat |
| Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 9 68 (11): 1911-1918. Sherman Kenneth E, Abdel-Hameed Enass, Rouster Susan D, Shata Mohamed Tarek M, Blackard Jason T, Safaie Parham, Kroner Barbara, Preiss Liliana, Horn Paul S, Kottilil Shy |
| Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression. PloS one 2019 14 (3): e0214421. Restrepo Clara, Gutierrez-Rivas Mónica, Pacheco Yolanda M, García Marcial, Blanco Julià, Medrano Luz M, Navarrete-Muñoz María A, Gutiérrez Félix, Miralles Pilar, Dalmau David, Gómez Juan Luis, Górgolas Miguel, Cabello Alfonso, Resino Salvador, Benito José M, Rallón Norma, |
| Association between the Genetic Polymorphisms of CCL2, CCL5, CCL8, CCR2, and CCR5 with Chronic Hepatitis C Virus Infection in the Chinese Han Population. Immunological investigations 2021 Apr 1-16. Shao Lin-Nan, Zhou Shi-Hang, Wang Ni, Zhang Shu-Ting, Liu Mi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: